AbbVie, Gilead and Allergan 3-peat with September’s top pharma TV spending – FiercePharma

Pharma TV ads seeming familiar lately? Thats in part because the same brands keep buying TV time. For the second month in a row, AbbVies Humira, Gilead Sciences'Truvada and Allergans Botox took the first, second and third spots on the top 10 pharma spenders list, according to data from real-time TV ad tracker iSpot.tv.

New to the fall listor newly returned, that isis seasonal spender Prevnar 13, Pfizers pneumococcal pneumonia vaccine. A new commercial continues Prevnar 13s continuing message, begun last year to people over 65, to get the vaccine so they dont miss out on what matters most.

Regeneron and Sanofi's Dupixent also returned to the top 10 with a September-debuted commercial that features four real patients who are shown skateboarding, cheerleading, playing pool and generally living their lives as a narrator talks over the action. With less eczema, you can show more skin. So roll up those sleeves, he says as the patients do just that.

De-Risking the Solid Form Landscape of an API

This presentation will discuss how predictable stability and solubility can minimize development timelines and cost. Attend to hear about two case studies exemplifying the importance of understanding the hydration space of an API and how hydrate formation may be avoided by development of a robust crystallization procedure.

The sole never-before brand on the list is AbbVies psoriasis treatment and Humira follow-up Skyrizi, which just launched its first ad campaign Nothing is Everything in late August after its May market debut.

Overall spending among the top 10 pharma TV spenders dropped in September down to $150 million after a strong August spend of $165 million, according to iSpot.

1. HumiraMovement: Stayed sameWhat is it? AbbVie anti-inflammatory drugTotal estimated spending: $36.6 million (down from $43.8 million in August)Number of spots: Seven(Four for arthritis, two for ulcerative colitis/Crohn's, one for psoriasis)Biggest-ticket ad: Keep Us Apart (est. $8.1 million)

2. TruvadaWhat is it? Gilead Sciences' HIV and PrEP drugTotal estimated spending: $22 million (down from $25.7 million in August)Number of spots: OneBiggest-ticket ad: On the Pill

3. BotoxMovement: Stayed sameWhat is it? Allerganneurotoxin treatment for migraines and aesthetic useTotal estimated spending: $14.6 million (down from $20.8 million in August)Number of spots: Seven (Two for cosmetic, five for migraine)Biggest-ticket ad: Own Your Look (est. $5.3million)

4. DupixentMovement: Not on list last monthWhat is it? Regeneron and Sanofiatopic dermatitis injectionTotal estimated spending: $14 millionNumber of spots: TwoBiggest-ticket ad: Roll Up Your Sleeves (est. $12.8 million)

5. Prevnar 13Movement: Not on list last monthWhat is it? Pfizer's pneumococcal pneumonia vaccineTotal estimated spending: $11.31millionNumber of spots: OneBiggest-ticket ad: Dont Miss Out on Life: Wedding

6. EliquisMovement: Down from No. 4What is it? Pfizer and Bristol-Myers Squibb next-gen anticoagulantTotal estimated spending: $11.3million (down from $16.4 million in August)Number of spots: FourBiggest-ticket ad: Travel (est. $5.2million)

7. OzempicMovement: Up from No. 9What is it? Novo Nordisk GLP-1 diabetes medTotal estimated spending: $11 million (up from $8.4 million in August)Number of spots: OneBiggest-ticket ad: Minigolf: Oh, Ozempic!

8. JardianceMovement: Down from No. 6What is it? Eli Lilly and Boehringer Ingelheim SGLT2 diabetes treatmentTotal estimated spending: $10.5 million (down from $11.6 million in August)Number of spots: TwoBiggest-ticket ad: Audrey Is on It: Marching Band (est. $7.5 million)

9. SkyriziMovement: Not on list last monthWhat is it? AbbVie IL-23 psoriasis treatmentTotal estimated spending: $10.4 millionNumber of spots: ThreeBiggest-ticket ad: "Feel Free to BareYour Skin" (est. $4.7 million)

10. IbranceMovement: Stayed sameWhat is it? Pfizermetastatic breast cancer fighterTotal estimated spending: $8.4 million (up from $8.2 million in August)Number of spots: TwoBiggest-ticket ad: Your Moment" (est. $7.5 million)

Go here to read the rest:
AbbVie, Gilead and Allergan 3-peat with September's top pharma TV spending - FiercePharma